Top compounds associated with response to MAP1S


Feature Type Standardized
Nominal ANOVA
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.13 8e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 9e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA Imatinib GDSC1000 pan-cancer AAC 0.2 0.0001
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA foretinib GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA Axitinib GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.13 0.0004
Download CSV